abstract |
The invention concerns novel 2-arylimino-2,3-dihydrothiazole derivatives, the methods for preparing them and their use as medicines, in particular for treating pathological conditions or diseases wherein one (or several) somatostatin receptors are involved. Said conditions include in particular acromegaly, hypophisial adenoma or endocrinal gastroentero-pancreatic tumours including the carcinoid syndrome, and gastrointestinal bleeding. |